MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04121nam a22004575i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
978-0-387-88611-4 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20251006084428.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100301s2009 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780387886114 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
99780387886114 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1007/978-0-387-88611-4 |
| Source of number or code |
doi |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
614.5999 |
| Edition information |
23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Salter, Russell D. |
| Relator term |
editor. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Dendritic Cells in Cancer |
| Medium |
[electronic resource] / |
| Statement of responsibility, etc. |
edited by Russell D. Salter, Michael R. Shurin. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York, NY : |
| Name of producer, publisher, distributor, manufacturer |
Springer US, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2009. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Other physical details |
online resource. |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
ALTERATIONS OF THE DENDRITIC CELL SYSTEM IN CANCER -- The Central Role of Dendritic Cells in Immunity -- Dendritic Cells in Cancer: Emergenceof the Discipline -- Tumor-Infiltrating Dendritic Cells: The Pathologist's Perspective -- Functional Defects of Dendritic Cells in Cancer -- General Properties of Dendritic Cell Populations in Cancer -- Elimination of Dendritic Cells in Cancer -- Mechanisms of Dendritic Cell Dysfunction in Cancer -- Tumor-Derived Factors Responsible for Dendritic Cell Dysfunction -- Tumor-Derived Exosomes as Dendritic Cell Modulators -- Signaling Pathways Mediating Dendritic Cell Dysfunction in Cancer -- A Role for STAT3 in Dendritic Cell Regulation by Tumor-Derived Factors -- Tumor-Associated Inflammation and Impact on Dendritic Cell Function -- Changes in Dendritic Cells in Cancer and Aging -- Stress, Immunity and Dendritic Cells in Cancer -- Cancer Therapy and Dendritic Cell Immunomodulation -- Role of Dendritic Cells in Tumor Escape -- Role of IDO in Dendritic Cell Differentiation and Function in Cancer -- Dendritic Cells: From Inducers of Specific T-Cell Responses to Promoters of Angiogenesis -- Protumorigenic Function of Dendritic Cells -- Dendritic Cell Maturation Versus Polarization in Tumor Escape -- Dendritic Cells in Cancer: Clinical Aspects -- Trafficking of Dendritic Cells in the Tumor Environment -- Dendritic Cells in Tumor-Draining Lymph Nodes -- Dendritic Cell Vaccines in Cancer: Obstaclesto Overcome -- How Best to Generate Dendritic Cells from Patients with Cancer and How Best to Use them for Immunotherapeutic Purposes -- Genetically Modified Dendritic Cells in Cancer Immunotherapy -- Dendritic Cell Tumors -- Future Directions in Dendritic Cell Research in Cancer. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Significant features of cancer are suppression and redirection of the immune response, which allow for tumor development and growth in the previously immune competent host. Central to development of immune responses are dendritic cells, and unsurprisingly these cells are strongly impacted by tumors and factors derived from them, as well as by other conditions associated with tumor progression or cancer treatments. Further, as some of the frontline strategies for treatment of cancer involve immunotherapy with ex vivo cultured or in vivo modulated dendritic cells, it becomes imperative to understand how dendritic cells interact with and are affected by the tumor microenvironment. "Dendritic Cells in Cancer," edited by Michael R. Shurin and Russell D. Salter, presents thorough analyses of the complex biology of the tumor-dendritic cell relationship, and offers insights into how cancer treatments may benefit from furthering our understanding in this area. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
MEDICINE. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
ONCOLOGY. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
TOXICOLOGY. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
CYTOLOGY. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
BIOMEDICINE. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
CANCER RESEARCH. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
CELL BIOLOGY. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
PHARMACOLOGY/TOXICOLOGY. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Shurin, Michael R. |
| Relator term |
editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Printed edition: |
| International Standard Book Number |
9780387886107 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="http://dx.doi.org/10.1007/978-0-387-88611-4">http://dx.doi.org/10.1007/978-0-387-88611-4</a> |
| Public note |
Ver el texto completo en las instalaciones del CICY |
| 912 ## - |
|---|
| -- |
ZDB-2-SBL |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Libros electrónicos |
